Botulinum toxin-B and the management of hyperhidrosis

Clinics in Dermatology

Volumn 22, Issue 1, 2004, Pages 60-65

  Baumann, Leslie S ^a,b   Halem, Monica L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b South Bldg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM CHLORIDE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CHOLINERGIC RECEPTOR BLOCKING AGENT;

CLINICAL TRIAL; CONJUNCTIVA DISEASE; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; DYSTONIA; EYE IRRITATION; HEARTBURN; HORNER SYNDROME; HUMAN; HYPERHIDROSIS; IMMUNITY; INDIGESTION; MICTURITION DISORDER; MUSCLE WEAKNESS; NAUSEA; PAIN; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN IRRITATION; SWEAT GLAND; SYMPATHECTOMY; SYSTEMIC DISEASE; TORTICOLLIS; VISUAL DISORDER; XEROSTOMIA;

EID: 2442667500     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.11.001     Document Type: Article

References (41)

1. Scott A.B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus. 17:1980;21-25
2. American Society for Aesthetic Plastic Surgery. 2000 Statistics on Cosmetic Surgery. New York: American Society for Aesthetic Plastic Surgery, 2001
3. Blitzer A, Binder WJ, Aviv JE, et al. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997;123:389-392
4. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum A exotoxin. J Dermatol Surg Oncol 1992;18:17-21
5. Carruthers A, Carruthers J. History of the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1168-1170
6. Naver H., Aquilonius S.M. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol. 4:1997;75-79
7. Naumann M. Evidence-based medicine: botulinum toxin in focal hyperhidrosis. J Neurol 2001;(Supp 1):31-33
8. Heckmann M., Breit S. Side-controlled intradermal injection of botulinum toxin type A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol. 41:1999;987-990
9. Heckmann M., Ceballos-Baumann A.O., Plewig G. Botulinum toxin type A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 344:2001;493-499
10. Goldman A. Treatment of axillary and palmar hyperhidrosis with botulinum toxin. Aesthetic Plast Surg. 24:2000;280-292
11. Naumann M. Evidence-based medicine botulinum toxin in focal hyperhidrosis. J Neurol. 248:2001;131-133
12. Holmes S., Mann C. Botulinum toxin in the treatment of palmar hyperhidrosis. J Am Acad Dermatol. 39:1998;1040-1041
13. Naver H., Swartling C., Aquilonius S.M., et al. Palmar and axillary hyperhidrosis treated with botulinum toxin one-year clinical follow-up. Eur J Neurol. 7:2000;55-62
14. Naumann M., Lowe N.J. Multicenter European axillary botulinum toxin type A study. BMJ. 323:2001;596-599
15. Naumann M, Lowe N. A randomized controlled parallel study evaluating botulinum toxin type A in the treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol 2000;14:53-55
16. Schnider P., Binder M., Auff E., et al. Double blind trial of botulinum toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 136:1997;548-552
17. Lowe NJ, Yamauchi PS, Lask GP, et al. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: A double-blinded randomized placebo-controlled study. Dermatol Surg 2002;28:822-827
18. Odderson I.R. Axillary hyperhidrosis treatment with botulinum toxin type A. Arch Phys Med Rehabil. 79:1998;350-352
19. Glogau R.G. Botulinum toxin type A for axillary hyperhidrosis. Dermatol Surg. 24:1998;817-819
20. Naumann M., Hofmann U., Bergmann I., et al. Focal hyperhidrosis. Effective treatment with intracutaneous botulinum toxin. Arch Dermatol. 134:1998;301-304
21. Wollina U., Karamfilov T., Konrad H. High-Dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol. 46:2002;536-540
22. Greene P., Fahn S., Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord. 9:1994;213-217
23. Zuber M., Sebald M., Bathien N., et al. Botulinum antibodies in dystonic patients treated with type A botulinum toxin frequency and significance. Neurology. 43:1993;1715-1718
24. Huang W., Foster J., Rogachefsky A. Pharmacology of botulinum toxin. J Am Acad Dermatol. 43:2000;249-259
25. Spencer J.M., Gordon M., Goldberg D.J. Botulinum B treatment of the glabellar and frontalis regions a dose-response analysis. J Cosmet Laser Ther. 4:2002;19-23
26. Lowe N.J., Yamauchi P.S., Lask G.P., et al. Botulinum toxins types A and B for brow furrows preliminary experiences with type B toxin dosing. J Cosmet Laser Ther. 4:2002;15-18
27. Ramirez A.L., Reeck J., Maas C.S. Botulinum toxin type B in the management of hyperkinetic facial lines. Otolaryngol Head Neck Surg. 126:2002;459-467
28. Schwetz BA. First drug for cervical dystonia. JAMA 2001;285:724
29. Brin M.F., Lew M.F., Adler C.H., et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology. 53:1999;1431-1438
30. Brashear A., Lew M.F., Dykstra D.D., et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology. 53:1999;1439-1446
31. Lew M.F., Adornato B.T., Duane D.D., et al. Botulinum toxin type B a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology. 49:1997;701-707
32. Baumann L. The cosmetic uses of botulinum toxin. Baumann L. Cosmetic dermatology principles and practice. 2002;139 McGraw-Hill, New York
33. Botulinum toxin advancement. Dermatol Times 2001, July 1
34. Baumann L, et al. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of botulinum toxin type B for the treatment of axillary hyperhidrosis (unpublished data)
35. Dressler D, Adib Saberi F, Benecke R. Botilinum toxin type B for treatment of axillar hyperhidrosis. J Neurol 2002;249:1729-1732
36. Baumann L. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of botulinum toxin type B for the treatment of palmar hyperhidrosis. Arch Dermatol 2003
37. Myobloc™ package insert. Dublin, Ireland: Elan Pharmaceuticals
38. Racette B.A., Lopate G., Good L., et al. Ptosis as a remote effect of therapeutic botulinum toxin type B injection. Neurology. 59:2002;1445-1447
39. Baumann L.S., Halem M.L. Systemic adverse effects after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhidrosis. Arch Dermatol. 139:2003;226-227
40. Dressler D., Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol. 49:2003;34-38
41. Matarasso S.L. Comparison of botulinum toxin types A and B a bilateral and double-blind randomization evaluation in the treatment of canthal rhytides. Dermatol Surg. 29:2003;7-13